Related Experiment Videos
Plasma exudation and oedema in asthma
1Department of Thoracic Medicine, National Heart & Lung Institute, London, UK.
British Medical Bulletin
|January 1, 1992
Summary
Plasma exudation and tissue edema are key features of asthma, driven by mediators. Corticosteroids may work by reducing this plasma leakage, suggesting broader anti-mediator drugs could be beneficial.
Area of Science:
- Pulmonary Medicine
- Pathology
- Pharmacology
Background:
- Asthma is characterized by inflammation and airway hyperresponsiveness.
- Plasma exudation and tissue edema are observed in asthmatic airways.
Purpose of the Study:
- To investigate the role of plasma exudation in asthma pathogenesis.
- To explore the mechanism of action for corticosteroid treatment in asthma.
Main Methods:
- Analysis of gross pathology, histology, and ultrastructure.
- Examination of sputum and lavage fluid from asthmatic patients.
- Experimental administration of mediators to induce plasma leakage.
Main Results:
- Plasma exudation from bronchial microvasculature and tissue edema are characteristic of asthma.
- Mediators inducing plasma exudation are present in asthmatic patients.
- Plasma exudate contributes to airway wall thickening, mucus plugs, and other asthma pathologies.
Conclusions:
- Plasma exudation is a significant factor in asthma pathology.
- Corticosteroids may exert beneficial effects by inhibiting plasma leakage.
- Broad-spectrum anti-mediator drugs may offer therapeutic advantages over specific receptor antagonists.